Abstract:Glioblastoma (GBM) is a highly lethal brain cancer, comprising about half of all central nervous system malignancies. Its recurrence and resistance to aggressive treatments, such as surgery, radiation, and chemotherapy, underscore its biological complexity. A key feature of GBM is intra-tumoral heterogeneity (ITH), stemming from a diversity of transcriptional cell states within the tumor. While genetic contributions to ITH are well-researched, the role of non-genetic factors, especially in promoting transitions between the various transcriptional cell states (referred to as plasticity), is less understood. This plasticity enables GBM cells to survive treatment pressures, necessitating a deeper dive into the epigenetic underpinnings that govern it and the role of the tumor microenvironment (TME) in influencing it. We proposed that the TME significantly impacts the epigenetic landscape of both malignant and surrounding non-malignant cells, thereby promoting ITH and cell state plasticity. To assess this, we analyzed samples from different anatomical areas of GBM tumors collected using MRI-guided selection. Utilizing advanced multimodal single-cell sequencing technologies, we profiled the transcriptomes and epigenomes of individual cells, revealing their spatially dependent phenotypic and epigenetic diversity. Our results indicated a higher enrichment of progenitor-like malignant cells, resembling neural or oligodendrocyte progenitors, around the tumor margins. In contrast, the core mainly contained differentiated cells with mesenchymal-like characteristics. Intriguingly, progenitor-like cells in the peri-tumoral zone expressed a unique neuronal activity program, including elevated levels of PRC2 complex targets, which are critical for maintaining the pluripotency and self-renewal capabilities of neural stem cells. Additionally, our analysis of cell-cell interactions between neurons and malignant cells identified ligand-receptor pairs crucial for axon guidance, neurogenesis, and tumor invasion. Proneural factors, critical for neural differentiation, were more accessible in peri-tumoral progenitor-like cells, suggesting that malignant cells might exploit neurodevelopmental routes for growth and invasion. This work underscores the significant spatial cellular heterogeneity of GBM and the variation in epigenetic states across the tumor, demonstrating how GBM cells can hijack neurodevelopmental pathways to foster invasion. Although surgical resection can target the tumor core, our insights into the invasive mechanisms of malignant cells provide a foundation for developing targeted therapies to combat the highly invasive cells persisting in regions adjacent to the tumor. Citation Format: Federico Gaiti, Yiyan Wu, Sheila Mansouri, Benson Wu, Yosef Ellenbogen, Xuyao Li, Parnian Habibi, Joan Kant, Pathum Kossinna, Sandra Ruth Lau Rodriguez, Gelareh Zadeh. Exploring spatially resolved intra-tumoral heterogeneity of glioblastoma and neuronal mechanisms facilitating brain invasion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5666.

Abstract 1484: CD57 Defines a Novel Maker of Glioblastoma Stem Cells That Have Greater Invasive Potential Than CD133+ Tumor Cells

SC-26CD57 DEFINES A NOVEL MAKER OF GLIOBLASTOMA STEM CELLS THAT HAVE GREATER INVASIVE POTENTIAL THAN CD133+ TUMOR CELLS

CD57 Defines a Novel Cancer Stem Cell That Drive Invasion of Diffuse Pediatric-Type High Grade Gliomas

Elevated Invasive Potential of Glioblastoma Stem Cells.

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors

Aggressive invasion is observed in CD133 - /A2B5 + glioma-initiating cells.

Abstract 489: Micro-RNA Signature of Glioblastoma Multiforme Invasion: an in Vivo Study in Patient-Tumor Derived Orthotopic Xenograft Mouse Models

Abstract 1950: Whole Genome Microrna Profiling in Functionally Validated Invasive GBM Cells Identifies a Novel Set of Micrornas Driving GBM Invasion

Abstract 2781: GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM

Abstract 5666: Exploring spatially resolved intra-tumoral heterogeneity of glioblastoma and neuronal mechanisms facilitating brain invasion

Abstract B009: GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM

Abstract LB-114: Molecular and Lineage Analysis of Glioblastoma Stem Cells Identifies Clinically Relevant Models of Glioblatoma

Cross-platform Analysis Reveals Cellular and Molecular Landscape of Glioblastoma Invasion.

Tmic-82. Characterization Of Genetic Markers And Biological Processes Underlying The Transition Of Glioblastoma Cells From A Differentiated To A Stem-Cell-Like State

Enhanced Invasion in Vitro and the Distribution Patterns in Vivo of CD133+ Glioma Stem Cells.

Abstract 2435: Single cell spatial analysis identifies regulators of brain tumor initiating cells

Abstract LB-132: Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes

Abstract 570: Radiation Resistance of Orthotopic Glioblastoma Xenografts is Mediated by Increasing CD133+ Cell Fraction, Mobilizing G0 Cells into G1 Phase, and Activating Self-Renewal and Mesenchymal Genes

Abstract 3875: Glioblastoma mutational profiles drive cancer cell signaling and immune evasion

Single‐cell RNA‐seq reveals the invasive trajectory and molecular cascades underlying glioblastoma progression

CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling